Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihaela M Mocanu

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|January 1, 2009
Letter to the editor: "Zinc and cardioprotection: the missing link"Mihaela M Mocanu, Derek M Yellon
FEBS Letters|December 4, 2003
p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioningMihaela M Mocanu, Derek M Yellon
Cardiovascular Drugs and Therapy|September 6, 2007
The power of drug co-administration: smaller doses better outcomesMihaela M Mocanu, Padmanabhan Shakkottai, Derek M Yellon
Journal of the American College of Cardiology|April 20, 2005
Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?Kwabena Mensah, Mihaela M Mocanu, Derek M Yellon
American Journal of Physiology. Heart and Circulatory Physiology|September 18, 2002
Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injuryHelen L Maddock, Mihaela M Mocanu, Derek M Yellon
Journal of Cardiovascular Pharmacology|February 24, 2005
Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signalingChristopher A Efthymiou, Mihaela M Mocanu, Derek M Yellon
Journal of Cardiovascular Pharmacology|November 25, 2005
Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPKAbigail M Wynne, Mihaela M Mocanu, Derek M Yellon
Journal of Molecular and Cellular Cardiology|June 11, 2002
PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioningMihaela M Mocanu, Robert M Bell, Derek M Yellon
Circulation Research|August 19, 2006
Is this truly ischemic preconditioning?Derek J Hausenloy, Mihaela M Mocanu, Derek M Yellon
Cardiovascular Drugs and Therapy|June 17, 2006
A potential role for PTEN in the diabetic heartMihaela M Mocanu, Duncan C Field, Derek M Yellon
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Physiology. Heart and Circulatory Physiology|January 1, 2009
Letter to the editor: "Zinc and cardioprotection: the missing link"Mihaela M Mocanu, Derek M Yellon
FEBS Letters|December 4, 2003
p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioningMihaela M Mocanu, Derek M Yellon
Cardiovascular Drugs and Therapy|September 6, 2007
The power of drug co-administration: smaller doses better outcomesMihaela M Mocanu, Padmanabhan Shakkottai, Derek M Yellon
Journal of the American College of Cardiology|April 20, 2005
Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?Kwabena Mensah, Mihaela M Mocanu, Derek M Yellon
American Journal of Physiology. Heart and Circulatory Physiology|September 18, 2002
Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injuryHelen L Maddock, Mihaela M Mocanu, Derek M Yellon
Journal of Cardiovascular Pharmacology|February 24, 2005
Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signalingChristopher A Efthymiou, Mihaela M Mocanu, Derek M Yellon
Journal of Cardiovascular Pharmacology|November 25, 2005
Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPKAbigail M Wynne, Mihaela M Mocanu, Derek M Yellon
Journal of Molecular and Cellular Cardiology|June 11, 2002
PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioningMihaela M Mocanu, Robert M Bell, Derek M Yellon
Circulation Research|August 19, 2006
Is this truly ischemic preconditioning?Derek J Hausenloy, Mihaela M Mocanu, Derek M Yellon
Cardiovascular Drugs and Therapy|June 17, 2006
A potential role for PTEN in the diabetic heartMihaela M Mocanu, Duncan C Field, Derek M Yellon
Pageof 4